Management of COVID-19: Other drugs and convalescent plasma Source: ERS Course 2021 - COVID-19: State of the art Year: 2021
Addition of convalescent plasma to systemic corticosteroids in early phase of COVID-19 Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma Source: Eur Respir J, 59 (2) 2101724; 10.1183/13993003.01724-2021 Year: 2022
Convalescent plasma therapy in COVID-19 patients: Chinese and European perspectives Source: ERS webinar 2020: Convalescent plasma therapy in COVID-19 patients: Chinese and European perspectives Year: 2020
Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection Source: Eur Respir J 2013; 42: 547-550 Year: 2013
Serum pharmacokinetics of antituberculosis drugs in volunteers Source: Eur Respir J 2004; 24: Suppl. 48, 721s Year: 2004
Serum acute phase reactants in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002
The dynamics of blood plasma antioxidant activity in patients with asthma exacerbation during the course of Phosphogliv admission Source: Eur Respir J 2007; 30: Suppl. 51, 616s Year: 2007
Analysis of serum cytokine levels before and after isoprinosine treatment in children with acute viral respiratory infections Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010
The efficacy of convalescent plasma therapy in severe COVID-19 patients: a systematic review Source: Virtual Congress 2021 – COVID19, acute respiratory failure and basic science Year: 2021
Convalescent Plasma does not improve in-hospital mortality among low SARS-CoV-2-IgG antibodies in COVID-19 hospitalized patients Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021
Serum ECP in comparison to sputum ECP measurements in symptomatic and asymptomatic subjects with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001
Erythrocyte and blood plasma antioxidant system status during the community-acquired pneumonia acute period Source: Eur Respir J 2006; 28: Suppl. 50, 1s Year: 2006
Effects of different serum theophylline concentrations on erythropoietin and hematocrit levels in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 422s Year: 2003
Altered IgG but normal IgA responses to pneumococcal proteins in lung fluid and serum in HIV infected adults Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010
Serum and bronchoalveolar lavage fluid acute phase reactants and cytokine levels in unilateral community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 418s Year: 2002
Plasma levels of sP- and sL-selectin in early and late asthmatic responders after allergen challenge Source: Eur Respir J 2003; 22: Suppl. 45, 413s Year: 2003
Level of C-reactive protein in blood serum of patients with MDR tuberculosis before and after treatment Source: Eur Respir J 2007; 30: Suppl. 51, 201s Year: 2007
Simultaneous analysis of sputum and serum biomarkers in adult asthma Source: International Congress 2019 – Clinical implications of asthma management Year: 2019
Relationship of serum immunoglobulines and IgG subclasses in previously healthy adult patients with community acquired pneumonia Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009